Has Clearwater Analytics (CWAN) Repricing Opened A Window After Recent Share Price Weakness?

  • For investors wondering whether Clearwater Analytics Holdings is attractively priced or still expensive at around US$23.25, this article walks through what the current share price might imply about the company’s underlying value.
  • The stock has seen a 1.2% decline over the last 7 days, a 2.4% decline over 30 days, a 3.6% decline year to date, and a 15.6% decline over 1 year, while the 3 year return sits at 65.5%. This performance can leave investors questioning whether the recent weakness changes the balance between risk and opportunity.
  • Recent coverage of Clearwater Analytics has focused on its role as a provider of software for investment accounting and reporting, and on how recurring usage by institutional clients can influence sentiment during shorter term share price moves. This context helps explain why some investors may see the recent pullback differently, depending on their view of the business model and long term demand for its services.
  • Right now, Clearwater Analytics scores a 1 out of 6 valuation check. Next, we will look at how traditional methods like the price-to-earnings ratio and discounted cash flow compare with each other, and then finish with a broader way to think about value that goes beyond any single metric.

Clearwater Analytics Holdings scores just 1/6 on our valuation checks. See what other red flags we found in the full valuation breakdown.

Advertisement

Approach 1: Clearwater Analytics Holdings Discounted Cash Flow (DCF) Analysis

A DCF model takes the cash Clearwater Analytics Holdings is expected to generate in the future, then discounts those projections back to today to estimate what the business might be worth in total and per share.

For Clearwater Analytics, the model uses last twelve months Free Cash Flow of about $165.3 million and projects this forward using a 2 Stage Free Cash Flow to Equity approach. Analyst estimates are used where available, and Simply Wall St extrapolates further out, with projected Free Cash Flow of $425 million by 2030. All figures are in $ and remain below $1b, so they are discussed in millions.

On this basis, the DCF model points to an estimated intrinsic value of about $24.35 per share. Compared with the current share price near $23.25, the model implies the stock trades at roughly a 4.5% discount, which is a small gap and could reasonably be seen as within a normal margin of error for this type of analysis.

Result: ABOUT RIGHT

Clearwater Analytics Holdings is fairly valued according to our Discounted Cash Flow (DCF), but this can change at a moment's notice. Track the value in your watchlist or portfolio and be alerted on when to act.

CWAN Discounted Cash Flow as at Mar 2026
CWAN Discounted Cash Flow as at Mar 2026

Head to the Valuation section of our Company Report for more details on how we arrive at this Fair Value for Clearwater Analytics Holdings.

Approach 2: Clearwater Analytics Holdings Price vs Sales

For companies where investors are focusing more on revenue than profits, the P/S ratio is often a useful way to think about value, because it compares what the market is paying to each dollar of sales.

What counts as a reasonable P/S ratio usually reflects the balance between growth expectations and risk. Higher growth and perceived resilience can support a higher multiple, while slower growth or higher risk tends to point to a lower, more conservative range.

Clearwater Analytics currently trades on a P/S of 9.36x, compared with the wider Software industry average of 3.50x and a peer average of 6.16x. Simply Wall St’s Fair Ratio for the company is 4.88x. This Fair Ratio is a proprietary estimate of what the P/S might be based on factors such as earnings growth, profit margins, industry, market cap and specific risks. It aims to be more tailored than a simple comparison with peers or the industry.

Since the current 9.36x P/S sits meaningfully above the 4.88x Fair Ratio, the P/S approach points to Clearwater Analytics trading on a richer valuation than those fundamentals alone would suggest.

Result: OVERVALUED

NYSE:CWAN P/S Ratio as at Mar 2026
NYSE:CWAN P/S Ratio as at Mar 2026

P/S ratios tell one story, but what if the real opportunity lies elsewhere? Start investing in legacies, not executives. Discover our 20 top founder-led companies.

Upgrade Your Decision Making: Choose your Clearwater Analytics Holdings Narrative

Earlier we mentioned that there is an even better way to understand valuation, so let us introduce you to Narratives. These are simple stories you create about Clearwater Analytics Holdings that connect your view of its business, your assumptions for future revenue, earnings and margins, and your own fair value estimate. All of this sits within an easy tool on Simply Wall St’s Community page that compares your fair value to today’s price, updates automatically as new news or earnings arrive, and even shows how different investors can look at the same company and reach very different conclusions. For example, some may see a higher fair value around US$36.00 while others may arrive at a lower figure near US$23.00, depending on how confidently they view the company’s acquisition plans, profitability and long term role in investment accounting software.

Do you think there's more to the story for Clearwater Analytics Holdings? Head over to our Community to see what others are saying!

NYSE:CWAN 1-Year Stock Price Chart
NYSE:CWAN 1-Year Stock Price Chart

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

New: AI Stock Screener & Alerts

Our new AI Stock Screener scans the market every day to uncover opportunities.

• Dividend Powerhouses (3%+ Yield)
• Undervalued Small Caps with Insider Buying
• High growth Tech and AI Companies

Or build your own from over 50 metrics.

Explore Now for Free

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com

About NYSE:CWAN

Clearwater Analytics Holdings

Develops and provides a Software-as-a-Service (SaaS) solution for automated investment data aggregation, reconciliation, accounting, and reporting services in the United States and internationally.

Reasonable growth potential with adequate balance sheet.

Similar Companies

Advertisement

Weekly Picks

LO
Lou_Basenese
OPTH logo
Lou_Basenese on Optimi Health ·

The Only Psychedelic Company Already Selling MDMA and Psilocybin to Real Patients, Yet Priced Like It Doesn’t Exist

Fair Value:US$1157.5% undervalued
47 users have followed this narrative
2 users have commented on this narrative
7 users have liked this narrative
WE
WealthAP
NOVO B logo
WealthAP on Novo Nordisk ·

Novo Nordisk (NVO): Is the "Easy Growth" Story Over?

Fair Value:DKK 407.7721.4% undervalued
68 users have followed this narrative
0 users have commented on this narrative
8 users have liked this narrative
VA
ValueInvestingSubstack
ZTS logo
ValueInvestingSubstack on Zoetis ·

Zoetis down -50% over the past year

Fair Value:US$92.9218.9% undervalued
23 users have followed this narrative
0 users have commented on this narrative
9 users have liked this narrative
CE
CentryResearch
LEU logo
CentryResearch on Centrus Energy ·

Centrus Energy: The Next Nuclear Bottleneck Isn't Reactors. It's Fuel.

Fair Value:US$19013.7% undervalued
24 users have followed this narrative
0 users have commented on this narrative
10 users have liked this narrative

Updated Narratives

WI
WisetoWealth
PYPL logo
WisetoWealth on PayPal Holdings ·

The Underrated Transformation of a Digital Payments Giant

Fair Value:US$90.3137.8% undervalued
2 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
BL
Blagget
TERA logo
Blagget on Terra Balcanica Resources ·

The C$4M Explorer Positioned to Become Europe's First Antimony Mine

Fair Value:CA$0.487.5% undervalued
2 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
DA
CHTR logo
david_6nroa on Charter Communications ·

Charter is undervalued - Here's why.

Fair Value:US$87.0741.6% overvalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative

Popular Narratives

CU
MSFT logo
CubanEros on Microsoft ·

A wonderful business at reasonable price.

Fair Value:US$419.919.1% undervalued
81 users have followed this narrative
0 users have commented on this narrative
6 users have liked this narrative
OS
oscargarcia
NVDA logo
oscargarcia on NVIDIA ·

The company that went from selling GPUs to gamers to becoming the AI arms dealer of the 21st century.

Fair Value:US$28026.1% undervalued
185 users have followed this narrative
9 users have commented on this narrative
15 users have liked this narrative
BE
PYPL logo
benjamin_lvieq on PayPal Holdings ·

PayPal: PayPal Doesn't Need to Grow – It Needs to Stop Falling – A Mispriced Cash Machine With a Cannibal Buyback

Fair Value:US$6513.6% undervalued
72 users have followed this narrative
2 users have commented on this narrative
11 users have liked this narrative

Trending Discussion

DE
TDOC logo
derek_3wsdg on Teladoc Health ·

You’ve overlooked the activist investor factor. Travis Cocke’s Voss has announced 5% ownership through a 13G filing. They’ve added to that 5% since, and in doing so, have created a structural trap door for 27.42 Million Shares actively sold short. Chuck will announce lots of positives on July 29 but it’s what Voss announces shortly after that will rock the overextended Teledoc shorts. The Walmart partnership is the tip of the iceberg. The market is missing the sheer regulatory and enterprise friction of modern corporate healthcare. Teladoc isn't a "consumer app"; it is the primary digital infrastructure integrated directly into the legacy backends of Tier-1 insurance companies and fortune 500 employers, covering 105 million+ lives. Teladoc is acting as the digital top-of-funnel engine for the world's largest retailer. If Voss pushes the narrative that Teladoc is effectively the outsourced digital brain of Walmart's entire healthcare footprint, the fair value shifts from a basic health multiple to an enterprise distribution premium. Additionally , we are in a structural gold rush for high-quality, legally compliant, longitudinal medical data to train vertical healthcare AI models. Large technology hyperscalers and pharmaceutical giants cannot simply scrape the internet for this; they need structured clinical inputs. Teladoc sits on one of the largest de-identified virtual medical datasets on earth. From the activist playbook , we’ll see Voss demand the immediate creation of a Data & Diagnostics Licensing Division, transforming a legacy liability into an incredibly high-margin, pure-software data asset that requires zero human clinician hours to scale. Chuck is doing great work and deserves credi5 for the Teledoc turnaround but it will be Travis Cocke who will be responsible for a share price way beyond your $15 valuation.

1
|
0